$JFIL
Jubilant Flame International, Ltd

2022 Form 10-K Financial Statement

#000147793222003101 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 2021 Q1 2021
Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Gross Profit $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Gross Profit Margin
Selling, General & Admin $79.27K $18.23K $84.19K
YoY Change -5.84% -19.26% -16.1%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $79.27K $18.23K $84.19K
YoY Change -5.83% -19.26% -16.12%
Operating Profit -$64.81K -$18.23K -$84.19K
YoY Change -23.01% -19.19% 10.55%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $14.46K
YoY Change
Pretax Income $0.00 -$18.23K $0.00
YoY Change -19.19% -100.0%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$64.81K -$18.23K -$84.19K
YoY Change -23.01% -19.19% 10.55%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$3.315K -$956.80 -$4.420K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 2021 Q1 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.580K $2.440K $2.440K
YoY Change 46.72% -77.05% -77.05%
Cash & Equivalents $2.441K
Short-Term Investments
Other Short-Term Assets $10.50K $9.000K $9.000K
YoY Change 16.67% 0.0% 0.0%
Inventory
Prepaid Expenses $9.000K
Receivables $0.00 $9.380K $9.380K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.08K $20.83K $20.83K
YoY Change -32.41% -28.26% -28.25%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $14.08K $20.83K $20.83K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $14.08K $20.83K $20.83K
YoY Change -32.41% -28.26% -28.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.000K $5.500K
YoY Change 27.27% -36.78%
Accrued Expenses $535.5K $535.5K $535.5K
YoY Change 0.0% 0.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $591.9K $551.1K $551.1K
YoY Change 7.41% 12.48% 12.48%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.182M $1.140M $1.140M
YoY Change 3.71% 5.36% 5.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.182M $1.140M $1.140M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.182M $1.140M $1.140M
YoY Change 3.71% 5.36% 5.36%
SHAREHOLDERS EQUITY
Retained Earnings -$3.592M
YoY Change
Common Stock $19.55K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.168M -$1.119M -$1.119M
YoY Change
Total Liabilities & Shareholders Equity $14.08K $20.83K $20.83K
YoY Change -32.41% -28.26% -28.25%

Cashflow Statement

Concept 2022 2021 Q1 2021
OPERATING ACTIVITIES
Net Income -$64.81K -$18.23K -$84.19K
YoY Change -23.01% -19.19% 10.55%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$39.68K -$12.33K -$69.37K
YoY Change -42.8% -5.66% 45.03%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $40.82K 7.350K $61.18K
YoY Change -33.28% -55.64% 32.02%
NET CHANGE
Cash From Operating Activities -$39.68K -12.33K -$69.37K
Cash From Investing Activities
Cash From Financing Activities $40.82K 7.350K $61.18K
Net Change In Cash $1.141K -4.980K -$8.187K
YoY Change -113.94% -242.29% 449.46%
FREE CASH FLOW
Cash From Operating Activities -$39.68K -$12.33K -$69.37K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
0 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
0 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-64811 USD
CY2022 dei Auditor Location
AuditorLocation
Sugar Land, Texas
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 USD
CY2021Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
9384 USD
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10500 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
14082 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
20825 USD
CY2022Q1 us-gaap Assets
Assets
14082 USD
CY2021Q1 us-gaap Assets
Assets
20825 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7000 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5500 USD
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
47643 USD
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
47643 USD
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
535500 USD
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
535500 USD
CY2022Q1 us-gaap Loans Payable Current
LoansPayableCurrent
591942 USD
CY2021Q1 us-gaap Loans Payable Current
LoansPayableCurrent
551124 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1182085 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1139767 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1182085 USD
CY2021Q1 us-gaap Liabilities
Liabilities
1139767 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19985708 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19548208 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
19986 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
19548 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2469045 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2453733 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3657034 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3592223 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1168003 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1118942 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14082 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20825 USD
CY2022 jfil Sales Of Goods
SalesOfGoods
0 USD
CY2021 jfil Sales Of Goods
SalesOfGoods
0 USD
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
79274 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
84186 USD
CY2022 us-gaap Operating Expenses
OperatingExpenses
79274 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
84186 USD
CY2022 us-gaap Other Income
OtherIncome
14463 USD
CY2021 us-gaap Other Income
OtherIncome
0 USD
CY2022 jfil Total Operating Income Loss
TotalOperatingIncomeLoss
14463 USD
CY2021 jfil Total Operating Income Loss
TotalOperatingIncomeLoss
0 USD
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-64811 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-84186 USD
CY2021 jfil Issued Stock Compensation
IssuedStockCompensation
18000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-69366 USD
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
40818 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-84186 USD
CY2022 jfil Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.00
CY2022 jfil Increasedecreaseinaccountsreceivable Writeoff
IncreasedecreaseinaccountsreceivableWriteoff
7384 USD
CY2021 jfil Increasedecreaseinaccountsreceivable Writeoff
IncreasedecreaseinaccountsreceivableWriteoff
0 USD
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18 USD
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
61179 USD
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1500 USD
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 USD
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1500 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3198 USD
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39677 USD
CY2021 jfil Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.00
CY2022 jfil Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
19549407 shares
CY2021 jfil Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
19049578 shares
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-1052756 USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
18000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-84186 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1118942 USD
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15750 USD
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-64811 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1168003 USD
CY2022 us-gaap Profit Loss
ProfitLoss
64811 USD
CY2021 us-gaap Profit Loss
ProfitLoss
84186 USD
CY2022 jfil Issued Stock Compensation
IssuedStockCompensation
15750 USD
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40818 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
61179 USD
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1141 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8187 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2441 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10628 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3582 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2441 USD
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s significant estimates include income tax provisions and valuation allowances of deferred tax assets; and the assumption that the company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p>
CY2022 jfil Aaccount Receivable Of Support Fee Write Off
AaccountReceivableOfSupportFeeWriteOff
7384 USD
CY2022Q1 jfil Working Capital Deficit
WorkingCapitalDeficit
-1168003 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3657034 USD
CY2022 us-gaap Professional Fees
ProfessionalFees
19000 USD
CY2022 jfil Note6 Accrued Officer Compensation And Stock Compensation
Note6AccruedOfficerCompensationAndStockCompensation
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 5 – ACCRUED OFFICER COMPENSATION AND STOCK COMPENSATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 15, 2015, the Company entered into an employment agreement with its president, Ms. Yan Li. The agreement was retroactively effective as of December 4, 2015, for a term of 36 months (measured from December 4, 2015). Pursuant to the agreement, both Ms. Yan shall receive an annual salary of $100,500 and 100,000 shares of the Company’s common stock. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 15, 2019, the board of the company approved new compensation to its five officers including two new appointed directors. The five directors waived their salary and will receive a total of 500,000 shares each year for a term of three years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of February 28, 2022, a total of $535,500 had been accrued as accrued officer compensation payable to its president compared to $535,500 as of February 28, 2021. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of February 28, 2022, a total of $15,750 in stock compensation expense had been recorded for five officers compared to a total of $18,000 in stock compensation recorded for the same period as of February 28, 2021.</p>
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
535500 USD
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
535500 USD
CY2022 jfil Other Income As A Portion Of Operating Expense
OtherIncomeAsAPortionOfOperatingExpense
22000 USD
CY2022 jfil Other Incone Write Off
OtherInconeWriteOff
7384 USD
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1052454 USD
CY2022 jfil Description Of Maturity Date For Income Tax
DescriptionOfMaturityDateForIncomeTax
future taxable income, if any, and which expire in various years through 2042.
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1052454 USD
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-12770 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-17679 USD
CY2022 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
3938 USD
CY2021 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
4935 USD
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
8832 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
12744 USD
CY2022 jfil Net Tax Expense
NetTaxExpense
0 USD
CY2021 jfil Net Tax Expense
NetTaxExpense
0 USD
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
8832 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
12744 USD
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
630 USD
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1155 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001

Files In Submission

Name View Source Status
0001477932-22-003101-index-headers.html Edgar Link pending
0001477932-22-003101-index.html Edgar Link pending
0001477932-22-003101.txt Edgar Link pending
0001477932-22-003101-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
jfil-20220228.xsd Edgar Link pending
jfil-20220228_cal.xml Edgar Link unprocessable
jfil-20220228_def.xml Edgar Link unprocessable
jfil-20220228_lab.xml Edgar Link unprocessable
jfil-20220228_pre.xml Edgar Link unprocessable
jfil_10k.htm Edgar Link pending
jfil_10k_htm.xml Edgar Link completed
jfil_ex311.htm Edgar Link pending
jfil_ex312.htm Edgar Link pending
jfil_ex321.htm Edgar Link pending
jfil_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending